X
Phone: +99871 253 20 51 | info@gmed.uz

Prostate cancer is one of the most common cancers in men.

In Russia, it occupies one of the leading places among the malignant diseases of the male population.

In the structure of cancer incidence, prostate cancer ranks third after lung and stomach cancer and fourth among the causes of death of cancer patients.

To this it should be added that due to the lack of screening programs for early detection of the disease, its diagnosis is imperfect.
Most cases of the disease are diagnosed at 3-4 stages, including 25% with generalization of the tumor process.

Today, mortality from prostate cancer in men is in second place after lung cancer.

Prostate cancer can develop in absolutely any man over 45-50 years old.

The causes of this disease are not fully understood. The development of prostate cancer is associated with hormonal changes in older men, in particular, with high levels of testosterone, the male sex hormone.

Prostate cancer is a hormone-dependent tumor, that is, the growth of the tumor is stimulated by testosterone. Therefore, in men with higher testosterone levels in the blood, the occurrence of prostate cancer is more likely and its course will be more malignant.

Prostate cancer is slow and malignant. This means that the tumor grows slowly (if you compare it, say, with liver cancer), it may not appear for many years. On the other hand, prostate cancer gives early metastases, that is, a small tumor can already begin to spread to other organs. Most often, the spread goes to the bones (pelvis, hips, spine), lungs, liver, adrenal glands. This is the greatest danger of cancer.

TREATMENT

The best and most progressive method today is the determination of PSA in the blood - the so-called prostate-specific antigen. This is a substance, the amount of which in the blood increases dramatically when cancer occurs in the prostate. The advantage of this method is that today it is practically the only way to suspect prostate cancer at a very early stage, when it can still be removed. The method is very simple and looks like a regular blood test 

 

to the patient. The disadvantages of the method include its very low prevalence in Russia and its relatively high cost.

Other studies - ultrasound, X-ray methods, can only more accurately determine the size of the tumor and the condition of other organs.

You can safely start treatment, which we carry out as quickly and efficiently as possible in Tashkent. The Gatling Med clinic will make you feel confident in yourself and your health!